Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 571INDUSTRY 141NIH 51OTHER_GOV 11NETWORK 5INDIV 2FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasms 4Lipoma 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Rectal Neoplasms 1Osteosarcoma 1Neutropenia 1Neoplasm Metastasis 1Multiple Myeloma 1Lung Neoplasms 1Liver Neoplasms 1Esophageal Neoplasms 1Cancer Cachexia 1Breast Neoplasms 1Barrett Esophagus 1Anemia 1

Interventions

Everolimus 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × INDIV × Carcinoma, Hepatocellular × Clear all
NCT00775073 2012-04-30

Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001

Treiber, Gerhard

Phase 2 Completed
33 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00440934 2008-05-06

THBC002

Pasche, Boris, M.D.

Phase 2 Terminated
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡